Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
6.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

8.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Peptide Bonds02:43

Peptide Bonds

82.9K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.9K
Feedback Inhibition00:46

Feedback Inhibition

57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

3.2K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the Editor regarding the article "Metabolic dysfunction-associated steatotic liver disease and dietary intake characteristics in children and adolescents: A cross-sectional study".

Revista de gastroenterologia de Mexico (English)·2026
Same author

Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations.

European heart journal·2026
Same author

microRNA-17-5p modulates ventral hippocampal transcriptome and synaptic proteome: Implications for emotional regulation in adult male rats.

Neurobiology of disease·2025
Same author

Platelet COX and LOX enzymes orchestrate amyloid-β secretion via RhoA signaling: Implications for neurodegenerative diseases.

Free radical biology & medicine·2025
Same author

Effects of participatory research-based intervention on the improvement of lifestyles and sarcopenic parameters in young-old adults of rural areas of Tarragona province (Catalonia, Spain): A Cluster randomized, parallel, controlled study.

Geriatric nursing (New York, N.Y.)·2025
Same author

Evaluating consumer willingness to pay for Chiloé lamb: The impact of geographical indication.

Meat science·2025

Related Experiment Video

Updated: Feb 1, 2026

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

12.5K

The cAMP/PKA Pathway Inhibits Beta-amyloid Peptide Release from Human Platelets.

C Sepúlveda1, B Hernández1, C F Burgos2

  • 1Thrombosis Reasearch Center, Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, Chile; Centro de Estudios en Alimentos Procesados (CEAP), CONICYT-Regional, Gore Maule, R09I2001 Talca, Chile.

Neuroscience
|November 30, 2018
PubMed
Summary
This summary is machine-generated.

This study reveals that the cAMP/PKA pathway regulates amyloid-beta (Aβ) peptide secretion from human platelets. Inhibiting this pathway reduces Aβ production, offering new insights into Alzheimer

Keywords:
Alzheimer diseaseAβ peptidecAMPcalpainplatelet

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K
Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.7K

Related Experiment Videos

Last Updated: Feb 1, 2026

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

12.5K
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K
Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.7K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Hematology

Background:

  • Alzheimer's disease (AD) is linked to amyloid-beta (Aβ) peptide deposits and cerebral amyloid angiopathy (CAA).
  • Platelets are a significant source of circulating Aβ, contributing to inflammation and potentially CAA/AD pathogenesis.
  • Understanding Aβ regulation in platelets is crucial for AD research.

Purpose of the Study:

  • To investigate the role of the cAMP/PKA pathway in regulating calpain activation and Aβ secretion in human platelets.
  • To explore the effects of forskolin, a cAMP-elevating agent, on platelet function and Aβ release.

Main Methods:

  • Incubation of human platelets with forskolin to modulate cAMP levels.
  • Assessment of calpain activity and Aβ peptide secretion.
  • Utilizing protein kinase A inhibitors to confirm pathway involvement.

Main Results:

  • Forskolin treatment significantly inhibited platelet calpain activity.
  • This inhibition was reversible with a protein kinase A inhibitor, confirming pathway mediation.
  • Reduced calpain activity led to decreased amyloid precursor protein (APP) processing and lower Aβ secretion.

Conclusions:

  • The cAMP/PKA pathway is a key regulator of Aβ processing and release from human platelets.
  • Targeting this pathway in platelets may offer a novel therapeutic strategy for AD and CAA.
  • This research provides new mechanistic insights into Aβ peptide generation and secretion.